Company profile

ImmunOs Therapeutics AG

ImmunOs Therapeutics AG is leading the next generation of immunotherapies by fast-tracking new discoveries to enhance combination therapies with novel human immunomodulatory proteins that have a role in both the innate and adaptive immune system for cancer treatment.

ImmunOs Therapeutics AG

Source: startup.ch

More news about ImmunOs Therapeutics AG

20.10.2023 11:46

Early-stage pharmaceutical companies make strides in cancer- and immunotherapy
  • Background
    Please login or
    register to use the
    awards follow feature
    18.01.2023 16:00

    Green light for ImmunOs Therapeutics first clinical trial
  • Success
    Please login or
    register to use the
    awards follow feature
    14.10.2022 09:30

    International and seasoned board members for Switzerland
  • Expansion
    Please login or
    register to use the
    awards follow feature
    07.06.2022 14:00

    ImmunOs Therapeutics raises $74 Million to fund clinical trials
  • Financing
    Please login or
    register to use the
    awards follow feature
    10.01.2022 11:00

    Experienced top managers join start-ups
  • Expansion
    Please login or
    register to use the
    awards follow feature
    20.09.2021 11:00

    Startups welcome executives aboard
  • Support
    Please login or
    register to use the
    awards follow feature
    10.12.2019 11:42

    ImmunOs Therapeutics AG raises CHF 15M in Series A Financing
  • Financing
    Please login or
    register to use the
    awards follow feature
    01.10.2018 10:27

    UZH Life Sciences Fund and Schroder Adveq invest in ImmunOs Therapeutics

  • Financing
    Please login or
    register to use the
    awards follow feature
    ImmunOs Therapeutics AG

    Founded
    2014

    Kanton
    ZH

    Homepage

    rss